Other devices or equipment, such as sanitizing wipes, are generally covered
The US Food and Drug Administration on Monday approved a generic version of the daily injectable GLP-1 medicine liraglutide for people with type 2 diabetes, opening the door for lower-priced options to reach the market and help address a shortage
An Eli Lilly spokesperson told Stateline in a statement that Lilly will continue to pursue legal remedies against those who falsely claim their products are Mounjaro, Zepbound, or FDA-approved tirzepatide, including certain med-spas, wellness centers, online retailers, and compounding pharmacies. Some states are focusing their investigations specifically on medical spas and IV infusion clinics that offer compounded weight-loss medications
Ozari publishes flat-rate plans for Florida: $86/month equivalent on the 3-Month Starter Plan ($257 every 3 months, first-time GLP-1 users), $145/month on Quarterly ($435 every 3 months), or $175/month month-to-month
Because of its multi-system effects, LDN offers additional benefits beyond weight loss, including chronic pain relief, mood and mental health support, and gut health support
